Mild Cognitive Impairment (MCI)
203
64
71
46
Key Insights
Highlights
Success Rate
94% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
1.5%
3 terminated out of 203 trials
93.9%
+7.3% vs benchmark
2%
5 trials in Phase 3/4
13%
6 of 46 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 46 completed trials
Clinical Trials (203)
Alzheimer's Disease Research Center (ADRC) PET Component Study
A Study To Assess The Feasibility Of Indivi Mobile Application In Monitoring Cognitive Performance In Aging Population
Safety Assessment of H2 Inhalation in Patients With Mild Cognitive Impairment
Prevalence of Mild Cognitive Impairment and Dementia in Patients Admitted to Non-neurological Rehabilitation Wards
Medication Self-Management Technology for Older Adults
Designing a Spatial Navigation Intervention Protocol Informed by Region-specific Brain Activation for Mild Cognitive Impairment
Safety Of Nrtis for Alzheimer's Therapeutic Advancement in Singapore Study
Evaluation of a PMT Rehabilitation Nursing Plan for the Older Adults With MCI to Promote Cognitive Health
Gamma tACS to Improve Cognitive Function in Mild Cognitive Impairment
Use of a Mobile Brain-Body Imaging Approach to Evaluate the Effects of Rhythmic Auditory Stimulation on Gait and Brain Function in Alzheimer's Disease
Safety And Tolerability Of Gamma Glutamylcysteine (GGC) Oral Supplementation In MCI Patients
Innovative Cognitive Impairment Case Finding and Engagement for Diverse Participation in Alzheimer's Disease Care, Treatment, And Research
Assessing Treatment With High-phenolic EVOO Supplements for Neurovascular Activity
To Evaluate the Safety and Efficacy of RP902 Tablets
cMIND AI Web Tool Usability Study (Hong Kong)
Oral Motor and Cognitive Dual-Task Training (OMCDT) Program for Improving Oral and Cognitive Functions Among People With Oral Frailty
Digital Solutions for Predicting the Biological Mechanisms of Alzheimer's Disease Through the Analysis of Risk Factors
Cognitive Training and Neuroplasticity in Mild Cognitive Impairment: COGIT-2 Trial
Enhancing Attention in Elderly Using a Brain-Computer-Interface
Effect of a Probiotic Formula in Mild Cognitive Impairement